VivaGel condoms cleared for sale in NZ: Starpharma
Starpharma (ASX:SPL) and Ansell have received clearance to market their VivaGel co-branded condoms in New Zealand.
Ansell and its New Zealand distributor EBOS Group have completed all the regulatory requirements to sell the LifeStyles Dual Protect brand condoms in the market.
The condoms are coated with Starpharma’s VivaGel antimicrobial gel and carry the VivaGel brand on the packaging.
The New Zealand label for the products will state that VivaGel has been shown in lab studies to inactivate up to 99.9% of HIV, herpes and HPV.
Starpharma and Ansell are already selling the condoms in Woolworths stores across Australia and are seeking regulatory approval in more markets.
Another Starpharma licensee, Japan’s Okamoto Industries, has also won approval to sell VivaGel coated condoms in its domestic market.
Starpharma separately revealed it has moved its corporate office from Abbotsford in Victoria to Melbourne central. Its new address is the Baker IDI Building on Commercial Road.
Starpharma (ASX:SPL) shares were trading 1.02% lower at $0.485 as of around 1.30 pm on Tuesday.
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
2026 Snow Fellowship recipients to receive $24m in biomedical funding
Australian biomedical researchers Dr Deborah Burnett, A/Prof Sudarshini Ramanathan and Dr Ira...
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
